He got up and gave a very eloquent speech, and at the end of the  speech, there was a panel, and on the panel were these pharmaceutical executives and biochemists and clinicians and I'm sitting there and  I'm listening to them and most of the content  went straight over my head.
Levantou-se e fez um discurso eloquente. Depois do discurso houve um debate, no painel estavam executivos de farmacêuticas, bioquímicos, clínicos. Eu estava sentada a ouvi-los e não percebia a maior parte do que diziam.